Sector revisions DexCom, Inc. Xetra

Stocks

Market Closed - Xetra 11:35:36 2026-10-02 EDT			5-day change	1st Jan Change
76.40 ^EUR	-0.52%		-0.26%	+33.19%

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Nbr of analysts
DEXCOM, INC.	-	-	-	-	-	-
ABBOTT LABORATORIES						25
MEDTRONIC PLC						24
STRYKER CORPORATION						25
ESSILORLUXOTTICA						23
CENCORA, INC.						12
HOYA CORPORATION						15
BECTON, DICKINSON AND COMPANY						12
IDEXX LABORATORIES, INC.						12
DEXCOM, INC.						25
ALCON INC.						17
MEDLINE INC.						26
WEST PHARMACEUTICAL SERVICES, INC.						16
GUARDANT HEALTH, INC.						25
SARTORIUS STEDIM BIOTECH						14
TERUMO CORPORATION						13
STERIS PLC						8
SONOVA HOLDING AG						19
STRAUMANN HOLDING AG						19
ZIMMER BIOMET HOLDINGS, INC.						21
Average						18
Weighted average by Cap.						20